Canadian, European and US regulators have announced their initial reactions to the discovery of N-nitrosodimethylamine, a probable human carcinogen, in ranitidine-based drugs.
Ranitidine – used to treat heartburn and stomach ulcers – is available in both prescription and OTC channels
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?